全球混合成像市场 – 2029 年行业趋势和预测

市场分析和规模

慢性病病例的增加可以预见会促进市场的增长。其他一些特点包括对 PET/CT 混合成像的需求不断增加、由于其功能和解剖技能而使混合成像在临床应用中的程序不断增加、混合应用中的调查活动不断增加。

Data Bridge Market Research 分析称，2021 年混合成像市场规模为 76.3 亿美元，到 2029 年将飙升至 1083 万美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 4.47%。这表明市场价值。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

混合成像是两种或多种不同成像方法的组合，这些方法可以共同创造出新技术。混合成像的一些集合类型包括 SPET/CT 系统、PET/MR 系统、OCT/眼底成像系统、PET/CT 系统等。

报告范围和市场细分

Hybrid imaging Market Dynamics

Drivers

• Increasing significance of combination analysis of anatomic and molecular data

Analysis of illnesses is also a driver in the growth of hybrid imaging technique. Observing ahead the assistances of hybrid imaging and its growing usage in the diagnosis, the area of growth is the combination hybrid imaging of PET or SPECT with MRI.

• High prevalence of chronic diseases

Growing alertness about early analysis and the rise in the number of diagnostic procedures are the driving factors for developing the hybrid imaging system market.

Opportunities

• Increasing occurrences of chronic diseases, with cancer

The cardiovascular diseases (CVDs), and neurological disorders, owed to sedentary lifestyles, unhealthy diets and habits, such as smoking and alcohol consumption, describe the main influences driving the market growth. Also this, there has been extensive acceptance of medical imaging technologies to distinguish and monitor disease progression, which characterizes another major growth-inducing factor.

• Governments of various countries are taking favorable initiatives

For spreading awareness concerning the benefits of mobile imaging facilities and making heavy investments toward the growth of healthcare infrastructure. The evolving trend of remote patient checking and the rushing approval of telehealth services have catalyzed the product demand. Moreover, various scientific advancements, such as the addition of portable imaging expedients with informatics and advanced imaging techniques to facilitate remote data storage and patient history tracking, have accelerated the product implementation rate among healthcare experts.

Restraints/Challenges

High cost of the hybrid imaging devices, cumulative issues related with the radiation exposure, and dearth of skilled and trained specialists will further hamper the growth of market in the forecast period 2022-2029.

Some of the disadvantages for the growth of hybrid imaging system is site authorization, scientist training, physician training and participation of high cost for procedure among the deprived population.

This hybrid imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hybrid imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Hybrid imaging Market

As per the recent conclusions demonstrate that medical imaging services have been hit hard by the pandemic. The situation likely will not return to normal until health professionals have more possessions to combat the original coronavirus. After the global pandemic, it is obvious that there is a lack of procedures. Since several countries depend on importations for the imaging devices, this can cause a major interruption in the supply chain of devices. Consequently, it is uncertain whether the companies will be able to certify an adequate supply of products. A probable short-term supply disruption within companies and healthcare provider organizations for select imaging devices, as a direct result of demand surge, can occur.

Recent Development

• Dec-2019: General electric derived into corporation with Affidea, a provider of medical services. The partnership is meant at deploying imaging and digital technologies across Affidea's diagnostic imaging services network.
• Dec-2019: Hitachi teamed up with T-Systems North America for developing new Hitachi Vantara-powered managed services. These services target the probabilities and challenge that healthcare and life science customer's face around initiative imaging and other business operational systems.
• Nov-2019: Hitachi Healthcare partnered with Christie Innomed. Below this partnership, Christie is intended at dispensing its diagnostic and surgical ultrasound imaging systems in Canada.

Global Hybrid imaging Market Scope

The hybrid imaging market is segmented on the basis of type, price range, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

By Technology

X-ray Imaging Systems

X-ray Digital Imaging Systems

• Computed Radiography
• Direct Radiography

X-ray Analog Imaging Systems

• Computed Tomography (CT) Scanners
• High-slice CT Scanners
• Mid-slice CT Scanners
• Low-slice CT Scanners
• Ultrasound Systems
• 2D Imaging
• 3D and 4D Imaging
• Doppler Imaging
• Magnetic Resonance Imaging (MRI) Systems
• High- and Very-high-field MRI Systems
• 低场至中场 MRI 系统
• 超高场 MRI 系统
• 核成像系统 [单光子发射计算机断层扫描 (SPECT) 和光子发射断层扫描 (PET) 系统]

SPECT 市场

• 独立 SPECT 系统
• 混合 SPECT 系统

混合 PET 市场

根据技术，混合成像市场细分为X射线成像系统、计算机断层扫描（CT）扫描仪、超声波系统、磁共振成像（MRI）系统和核成像系统。X射线成像系统进一步细分为X射线数字成像系统和X射线模拟成像系统。X射线数字成像系统分为计算机放射成像和直接放射成像。计算机断层扫描（CT）扫描仪分为高切片CT扫描仪、中切片CT扫描仪和低切片CT扫描仪。超声波系统分为2D成像、3D和4D成像以及多普勒成像。磁共振成像系统分为高场和极高场MRI系统、低场至中场MRI系统和超高场MRI系统。核成像系统细分为SPECT市场和混合PET市场。SPECT市场进一步分为独立SPECT系统和混合SPECT系统。

应用

• 肿瘤学
• 放射科
• 神经病学
• 其他的

根据应用，混合成像市场细分为肿瘤学、放射学、神经病学、眼科学、心脏病学和其他。

最终用户

• PET/CT 系统
• SPET/CT 系统
• PET/MR 系统
• OCT/眼底成像系统
• 其他的。

根据类型，混合成像市场细分为 PET/CT 系统、SPET/CT 系统、PET/MR 系统、OCT/眼底成像系统等。

混合成像市场区域分析/见解

对混合成像市场进行了分析，并按国家、类型、价格范围、应用和最终用户提供了市场规模洞察和趋势。

混合成像市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

2018 年，北美占据了混合/多模态成像市场的主导地位，预计在预测期内将以惊人的速度增长。该地区的增长主要归功于全球参与者的存在以及混合成像设备等创新设备的日益普及。此外，该地区对核医学和分子诊断的认识不断提高，预计也将有助于该地区的增长。

亚太地区有望在预测期内实现最强劲的增长。这主要归因于新兴经济体放射科越来越多地使用 PET/CT 系统等先进设备。 

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

混合成像市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗支出的增长、混合成像市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对混合成像市场的影响。数据涵盖 2010-2020 年的历史时期。

竞争格局和混合成像市场份额分析

混合成像市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对混合成像市场的关注有关。

混合成像市场的一些主要参与者包括：

• 通用电气（美国）
• 西门子。（美国）
• 布鲁克 (美国)
• Mediso Ltd（英国）
• MILabs BV（荷兰）
• PerkinElmer Inc.（美国）
• FUJIFILM Visualsonics, Inc（加拿大）
• Cubresa Inc.（加拿大）
• Amber Diagnostics（美国）
• 佳能印度私人有限公司 (日本)
• 日立有限公司（日本）
• Koninklijke Philips NV（荷兰）
• 亚特兰蒂斯环球（美国）

SKU-52731